Member

Bench in a Box Technologies


Bench in a Box Technologies develops point-of-care diagnostic platforms tailored for field and low-resource environments. The company's core technology, Protein Signal Amplification (PSA), allows rapid, electricity-free molecular detection at room temperature, delivering results in five minutes or less, without the need for refrigeration or specialized laboratory infrastructure. Drawing on extensive expertise in molecular diagnostics, drug development, and logistics, the company aims to make high-quality diagnostics broadly accessible.

Industries

Clinical
Veterinary
Envrionmental
Medical Device

Nr. of Employees

small (1-50)

Bench in a Box Technologies

Bench in a Box Technologies is currently seeking investment

Bench in a Box Technologies is seeking a pre-seed investment in the range of 1m-5m

All Investment-seeking Members

Products

Protein Signal Amplification Diagnostic Platform

A hand-held, portable diagnostic platform providing molecular detection in less than five minutes using our proprietary Protein Signal Amplification chemistry. It's room temperature operation and lack of cold-chain logistics make it suitable for field and low-resource settings.

Expertise Areas

  • Molecular diagnostics
  • Point-of-care testing
  • Protein-based detection platforms
  • Rapid diagnostic development

Key Technologies

  • Protein signal amplification
  • Portable and hand-held diagnostic assays

Key People

Josh Smith

Founder & CEO

LinkedIn

Steven R. Watt

Advisor (COO, Atterx Biotherapeutics)

LinkedIn

Evan Friedmann

Advisor (VP, Helma USA & Scientific Cell Company)

LinkedIn

Nathan Johnson

Advisor (President & CEO, Verne Bioanalytics)

LinkedIn

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.